These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning. Konrath E; Marhold F; Kindler W; Scheichel F; Popadic B; Blauensteiner K; Calabek B; Freydl E; Weber M; Ristl R; Hainz K; Sherif C; Oberndorfer S BMC Neurol; 2022 Jul; 22(1):250. PubMed ID: 35804291 [TBL] [Abstract][Full Text] [Related]
63. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
64. Seizure Deterioration with Increased Levetiracetam Blood Concentration during the Postpartum Period in Refractory Temporal Lobe Epilepsy. Kikumoto M; Neshige S; Shishido T; Ueno H; Aoki S; Iida K; Maruyama H Intern Med; 2022 Apr; 61(8):1237-1240. PubMed ID: 34615824 [TBL] [Abstract][Full Text] [Related]
67. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus. Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109 [TBL] [Abstract][Full Text] [Related]
68. The long term retention of levetiracetam in a large cohort of patients with epilepsy. Depondt C; Yuen AW; Bell GS; Mitchell T; Koepp MJ; Duncan JS; Sander JW J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):101-3. PubMed ID: 16361605 [TBL] [Abstract][Full Text] [Related]
69. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types. Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559 [TBL] [Abstract][Full Text] [Related]
70. Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis. Fang T; Valdes E; Frontera JA Neurocrit Care; 2022 Feb; 36(1):248-258. PubMed ID: 34286461 [TBL] [Abstract][Full Text] [Related]
71. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy. Tanaka S; Tanaka T Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199 [TBL] [Abstract][Full Text] [Related]
72. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy. Hattori EY; Arakawa Y; Mineharu Y; Furukawa K; Terada Y; Yamao Y; Tanji M; Kikuchi T; Miyamoto S BMC Cancer; 2023 Sep; 23(1):849. PubMed ID: 37697277 [TBL] [Abstract][Full Text] [Related]
73. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. Misra UK; Kalita J; Maurya PK J Neurol; 2012 Apr; 259(4):645-8. PubMed ID: 21898137 [TBL] [Abstract][Full Text] [Related]
74. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam. Kinirons P; McCarthy M; Doherty CP; Delanty N Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211 [TBL] [Abstract][Full Text] [Related]
75. Levetiracetam dosing for seizure prophylaxis in neurocritical care patients. Hedges A; Findlay MC; Davis GE; Wolfe BM; Hawryluk GWJ; Menacho ST; Ansari S Brain Inj; 2023 Aug; 37(10):1167-1172. PubMed ID: 36856437 [TBL] [Abstract][Full Text] [Related]
76. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Talos DM; Chang M; Kosaras B; Fitzgerald E; Murphy A; Folkerth RD; Jensen FE Pediatr Res; 2013 Jan; 73(1):24-30. PubMed ID: 23138400 [TBL] [Abstract][Full Text] [Related]
77. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913 [TBL] [Abstract][Full Text] [Related]
78. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Brigo F; Bragazzi N; Nardone R; Trinka E Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657 [TBL] [Abstract][Full Text] [Related]
79. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting. Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN Seizure; 2017 May; 48():1-6. PubMed ID: 28363098 [TBL] [Abstract][Full Text] [Related]
80. New onset paediatric epilepsy in 1-5 years age group children--approach to management in a tertiary care centre with newer anti-epileptic levetiracetam. Barik KL; Paul UK; Bhattacharyya AK; Adhikary A; Agarwal G; Rana KS J Indian Med Assoc; 2014 Feb; 112(2):100-2. PubMed ID: 25935964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]